AURO-DARUNAVIR DIN 02486121
Status: Marketed
Holder: AURO PHARMA INC
Available to quote
Health Canada record
| Active ingredient(s) | DARUNAVIR (DARUNAVIR PROPYLENE GLYCOLATE) 600 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | J05AE10 DARUNAVIR |
| Original market date | 18-Mar-2020 |
| Current status date | 18-Mar-2020 |
| Source | Health Canada DPD |
Establishment licence of the holder
Auro Pharma Inc — licence 101305, currently licensed, last inspection rating C (2023-09-27).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing DARUNAVIR (DARUNAVIR PROPYLENE GLYCOLATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02486113 | AURO-DARUNAVIR | AURO PHARMA INC | Tablet | DARUNAVIR (DARUNAVIR PROPYLENE GLYCOLATE) 400 MG | Approved |
| 02486148 | AURO-DARUNAVIR | AURO PHARMA INC | Tablet | DARUNAVIR (DARUNAVIR PROPYLENE GLYCOLATE) 800 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 23066 | 2020-01-02 | Abbreviated New Drug Submission (ANDS) |